Sara Radović

Dr. Sara Radović

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Medicina
Verified
Journal Article
Open access
PDF file
IPIrena Ostric Pavlovic
Irena Ostric Pavlovic
SRSara Radović
Sara Radović
Danka KrtinićDanka Krtinić
Danka Krtinić
Jelena Spirić MilovančevićJelena Spirić Milovančević
Jelena Spirić Milovančević
NKNatasa Kusic
Natasa Kusic
VSVesna Tomic Spiric
Vesna Tomic Spiric
Introduction: Tryptase is an important biomarker widely used in the laboratory confirmation of severe hypersensitivity reactions, especially anaphylaxis. It also plays a crucial role in the diagnosis, risk stratification, management and prognostic evaluation of many other mast cell-related conditions. Aim: This paper aims to highlight the role of serum tryptase, both in allergic disorders and other mast cell-related conditions. Two clinical cases regarding timely serum tryptase acquisition (in drug hypersensitivity reactions during the imaging procedure and perioperative anaphylaxis) are meant to emphasize the clinical potential of this protease. Method: We performed a comprehensive literature search of the PubMed/Medline and Scopus databases. From a total of 640 subject related publications, dating from 1940 to 2024, 45 articles written in English were selected. Literature search results: Total serum tryptase is a simple, cost-effective analysis with a normal baseline tryptase (sBT) level below 8.4 µg/L. Elevated sBT can indicate hereditary alpha-tryptasemia (HαT), mastocytosis and other non-allergic disorders. Patients with higher sBT levels, especially with insect venom allergy, have an increased risk of severe reactions and thereby require a prolonged treatment. All immediate systemic hypersensitivity reactions require a correlation between serum acute tryptase (sAT) and sBT. According to the guidelines, measuring sAT 30 min to 2 h after the symptom onset and sBT 24 h after the resolution, using the 20 + 2 rule and an sAT/sBT ratio of 1.685, improves the diagnostic accuracy in anaphylaxis. Conclusions: Tryptase levels should be acquired in all cases with clinical suspicion of MC degranulation. Given the increasing clinical relevance, elevated baseline serum tryptase levels require a multidisciplinary approach and further investigation.

16 September 2024 in Rheumatology International
Verified
Journal Article
Closed access
Rada MiskovicRada Miskovic
Rada Miskovic
SRSara Radović
Sara Radović
SASnezana Arandjelovic
Snezana Arandjelovic
APAleksandra Plavsic
Aleksandra Plavsic
VRVesna Reljic
Vesna Reljic
Maja StojanovicMaja Stojanovic
Maja Stojanovic

11 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
DJDragana Jovanovic
Dragana Jovanovic
Rada MiskovicRada Miskovic
Rada Miskovic
APAleksandra Plavsic
Aleksandra Plavsic
SRSara Radović
Sara Radović
LNLjudmila Nagorni-Obradovic
Ljudmila Nagorni-Obradovic
BBBranka Bonaci-Nikolic
Branka Bonaci-Nikolic
Background/Objectives: Binding of bactericidal/permeability-increasing (BPI) protein to Gram-negative (GN) bacteria plays a major role in bacterial elimination. The relationship between BPI-antineutrophil cytoplasmic autoantibodies (ANCA), persistent infections and immunoinflammatory diseases has not been elucidated. Methods: In total, 193 ANCA-positive patients detected by IIF with ANCA-associated vasculitides (AAV, n-40), connective tissue diseases (CTD, n-28), drug-induced vasculitides (DIV, n-17), ulcerative colitis (UC, n-24), UC with primary sclerosing cholangitis (UC/PSC, n-14), Crohn’s disease (CD, n-10), autoimmune hepatitis (AIH, n-19) and chronic infections (n-41) were tested using the BPI-ANCA quantitative and semiquantitative ELISA (ANCA-profile: BPI, proteinase 3, myeloperoxidase, elastase, cathepsin G, lactoferrin). BPI-ANCA were analyzed in 52 healthy persons. Results: A total of 46/193 (23.8%) patients had BPI-ANCA positivity. BPI-ANCA were more frequently present in patients with prolonged GN bacterial infections and inflammatory bowel diseases than in AAV, DIV, AIH, CTD and healthy controls (p < 0.001). UC/PSC patients more frequently had BPI-ANCA than UC and CD patients (p < 0.001). GN bacterial infections more frequently had BPI-ANCA than Gram-positive bacterial infections (p < 0.001). Infections caused by Pseudomonas aeruginosa and Mycobacterium tuberculosis had monospecific BPI-ANCA (sensitivity 79% and 71%, respectively). UC/PSC and chronic GN bacterial infections caused by Klebsiella pneumoniae, Proteus mirabilis, or Escherichia coli had multispecific BPI-ANCA (sensitivity 64% and 100%, respectively). Odds ratio analysis showed that patients with IBD who were positive for multispecific BPI-ANCA had a 13.5-fold increased risk of UC/PSC (95% CI 2.98–61.18). Conclusions: Monospecific BPI-ANCA may be a valuable biomarker for persistent Pseudomonas aeruginosa and Mycobacterium tuberculosis infections. In contrast, multispecific BPI-ANCA are associated with UC/PSC and persistent infections caused by intestinal Gram-negative bacteria. Suppression of antimicrobial function by multispecific BPI-ANCA could impair the elimination of Gram-negative bacteria, sustaining the immunoinflammation. Dysregulated antimicrobial response might be the target of immunomodulatory therapy in the initial phase of BPI-ANCA-positive UC/PSC.

Verified
Journal Article
Open access
PDF file
APAleksandra Plavsic
Aleksandra Plavsic
Rada MiskovicRada Miskovic
Rada Miskovic
DJDragana Jovanovic
Dragana Jovanovic
UKUros Karic
Uros Karic
ZJZikica Jovicic
Zikica Jovicic
SASnezana Arandjelovic Arandjelovic
Snezana Arandjelovic Arandjelovic
Macrophage activation syndrome (MAS) is a complex, life-threatening, hyperinflammatory condition occurring as a form of hemophagocytic lymphohistiocytosis (HLH), commonly associated with several autoimmune and autoinflammatory diseases, and certain infections such as Parvovirus B19 (P19V). The onset of systemic lupus erythematosus (SLE) presenting as MAS during pregnancy is uncommon, posing significant diagnostic and therapeutic challenges. We present a case of a 30-year-old woman at the 12th gestational week with fever, arthralgia, rash, cervical lymphadenopathy, cytopenia, and elevated liver enzyme. Bone marrow biopsy revealing hemophagocytosis, elevated ferritin and triglycerides, high interleukin-2, fever and cytopenia, confirmed the diagnosis of HLH. Further evaluation revealed the diagnosis of SLE. Treatment was initiated with intravenous immunoglobulin and corticosteroids. Given the deterioration in the patient’s clinical condition, a decision was made to terminate the pregnancy. She continued in the following months to receive SLE treatment with corticosteroids, cyclophosphamide, hydroxychloroquine, and later with mycophenolate mofetil due to the development of Class IV of lupus nephritis. P19V IgM antibodies were initially positive, later seroconverted to IgG, indicating that infection may have acted as a trigger for the onset of SLE and MAS development during pregnancy. The overlapping clinical features of P19V infection, SLE, and MAS pose significant diagnostic and therapeutic challenges. Early recognition and comprehensive diagnostic evaluation are crucial for the management of these conditions, especially during pregnancy, where both maternal outcomes are at risk.

13 April 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SRSara Radović
Sara Radović
APAleksandra Plavsic
Aleksandra Plavsic
RMRada Miskovic
Rada Miskovic
ADAna Drazic
Ana Drazic
MTMilos Todorovic
Milos Todorovic
SASnezana Arandjelovic
Snezana Arandjelovic
Introduction: Parasitic infections are increasingly recognized as potential triggers of autoimmunity and vasculitis, though evidence remains limited. Toxocara canis (T.canis) , one of the most prevalent helminthic infections worldwide, has been sporadically linked to autoimmune phenomena through mechanisms such as molecular mimicry, immune complex formation, and chronic inflammation. Case report and literature review: We describe a 45-year-old woman who developed histologically confirmed small-vessel vasculitis of the intestine with perforation, accompanied by cutaneous vasculitis, arthralgia, pruritus, eosinophilia, and elevated IgE and seropositivity for T. canis . Surgical resection with ileostomy led to spontaneous clinical remission without the need for immunosuppressive therapy. Immunologic evaluation revealed two coexisting organ-specific autoimmune diseases not typically associated with vasculitis: autoimmune thyroiditis (Hashimoto’s) and autoimmune cholangitis. We reviewed the available literature on T. canis -associated autoimmunity and vasculitis, summarizing clinical presentations and patient outcomes. Conclusion: Our report of histopathologically confirmed cases of small-vessel intestinal vasculitis associated with T. canis , leading to bowel perforation and remission without immunosuppression suggests that T. canis infection may represent an underrecognized trigger of autoimmunity and vasculitis. This case, together with a comprehensive review of the literature, indicates that T. canis infection should be considered in patients presenting with eosinophilia and elevated IgE, especially when accompanied by systemic or vasculitic manifestations.

2 April 2025 in Anti-Aging Eastern Europe
Verified
Journal Article
Open access
SRSara Radović
Sara Radović
AVAnja Vrljes
Anja Vrljes
ADAleksandra Dasic
Aleksandra Dasic
Maja StojanovicMaja Stojanovic
Maja Stojanovic
Rada MiskovicRada Miskovic
Rada Miskovic
Recent research indicates that the age of disease onset plays a crucial role in shaping the phenotype of systemic autoimmune inflammatory diseases. Late-onset Sjögren’s syndrome (SS) presents unique diagnostic challenges due to symptom overlap with age-related conditions. Key issues include difficulties in interpreting tests for sicca syndrome, high prevalence of comorbidities, polypharmacy, and underutilization of salivary gland biopsy in older patients. This narrative review provides an overview of the clinical and immunological characteristics of late-onset SS, along with management strategies tailored to this population. Emphasis is placed on the need for an age-adjusted diagnostic approach and the value of multidisciplinary, holistic care for late-onset SS patients.